Air Pollution Exposure Tied to New Psoriasis
By Lori Solomon HealthDay Reporter
THURSDAY, July 18, 2024 -- Long-term exposure to air pollution is associated with the development of new psoriasis, according to a study published online July 16 in JAMA Network Open.
Junhui Wu, Ph.D., from the Peking University School of Nursing in Beijing, and colleagues examined the association between long-term exposure to air pollution and psoriasis and the interaction between air pollution and genetic susceptibility for incident psoriasis. The analysis included 474,055 individuals with a median follow-up of 11.91 years.
The researchers observed a positive association between the risk for psoriasis and air pollutant exposure. For fine particulate matter with a diameter <2.5 μm, fine particulate matter with a diameter <10 μm, nitrogen dioxide, and nitrogen oxides, every interquartile range increase yielded higher risk. Multivariate-adjusted risks were also higher when comparing individuals in the highest exposure quartile with those in the lowest exposure quartile. There were significant interactions between air pollution and genetic predisposition for incident psoriasis, with a substantial risk for psoriasis development in individuals exposed to the highest quartile of air pollution levels concomitant with high genetic risk versus those in the lowest quartile of air pollution levels with low genetic risk.
"There is a need to devise and implement effective interventions aimed at mitigating air pollution and safeguarding individuals from the effects associated with psoriasis," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Residual Inflammation Seen in One-Third of Patients With Psoriasis on Biologics
WEDNESDAY, May 21, 2025 -- For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by...
Psoriatic Arthritis Tied to Delays in Diagnosis Compared With Rheumatoid Arthritis
WEDNESDAY, April 30, 2025 -- Patients with psoriatic arthritis (PsA) have delays in diagnosis compared with those with rheumatoid arthritis (RA), according to a study published...
Flares Occur Frequently in Generalized Pustular Psoriasis
WEDNESDAY, April 16, 2025 -- Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents are frequently observed...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.